KCAT	Clostridium perfringens	8.5	dinitrophenyl alpha-N-acetyl-Dglucosaminide	*
KCAT	Clostridium perfringens	0.26	4-nitrophenyl alpha-N-acetyl-D-glucosaminide	*
KM	Clostridium perfringens	0.0011	4-nitrophenyl alpha-N-acetyl-D-glucosaminide	*in 0.1 M sodium phosphate, pH 7.3, at 30&deg;C
KM	Homo sapiens	0.04	N-[6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannosyl]-[uteroferrin]-L-asparagine	*
KM	Rattus sp.	0.19	methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose	*
KM	Homo sapiens	0.4	methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose	*full length enzyme
KM	Homo sapiens	0.43	methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose	*delta 102-bp variant
KM	Homo sapiens	0.45	methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose	*
KM	Bos taurus	0.49	methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose	*
KM	Bos taurus	0.734	UDP-GlcNAc	*
KM	Clostridium perfringens	0.74	dinitrophenyl alpha-N-acetyl-Dglucosaminide	*in 0.1 M sodium phosphate, pH 7.3, at 30&deg;C
KM	Bos taurus	0.74	methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose	*
KM	Homo sapiens	0.76	methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose	*
KM	Homo sapiens	0.78	UDP-GlcNAc	*
KM	Homo sapiens	0.94	UDP-GlcNAc	*
KM	Rattus sp.	1.3	UDP-N-acetylglucosamine	*
KM	Rattus sp.	1.6	N-acetylglucosamine 1-phosphate	*
KM	Homo sapiens	31	N-acetylglucosamine-phosphate	*
MW	Homo sapiens	-999	*	*1885 Da, peptides of amino acid position 80 to 84 and 268 to 274, determined by LC/ESI-MS/MS analysis, soluble form; 2797 Da, peptide of amino acid position 159 to 183, determined by MALDI-TOF and by LC/MS, soluble form; 2878 Da, peptide of amino acid position 331 to 355, determined by LC/MS, soluble form; 2925 Da, peptide of amino acid position 305 to 355, determined by MALDI-TOF and by LC/MS, soluble form; 3124 Da, peptides of amino acid position 54 to 69 and 94 to 108, determined by LC/ESI-MS/MS analysis, soluble form; 3230 Da, peptides of amino acid position 1 to 4 and 159 to 182, determined by LC/ESI-MS/MS analysis, soluble form; 4023 Da, peptide of amino acid position 228 to 264, determined by MALDI-TOF and by LC/MS, soluble form; 4337 Da, peptides of amino acid position 228 to 264 and 265 to 267, determined by LC/ESI-MS/MS analysis, soluble form; 880 Da, peptide of amino acid position 369 to 376, determined by MALDI-TOF, soluble form
MW	Bos taurus	68000	*	*liver, reducing SDS-PAGE
MW	Homo sapiens	69000	*	*brain, reducing SDS-PAGE
MW	Bos taurus	69000	*	*fetal calf serum, reducing SDS-PAGE
MW	Homo sapiens	69000	*	*
MW	Homo sapiens	77000	*	*liver, reducing SDS-PAGE
MW	Homo sapiens	80000	*	*x * 80000, sialylated UCE, SDS-PAGE
MW	Homo sapiens	114000	*	*lymphoblasts, nonreducing SDS-PAGE
MW	Homo sapiens	118000	*	*serum
MW	Bos taurus	121000	*	*liver, nonreducing SDS-PAGE
MW	Bos taurus	129000	*	*liver, nonreducing SDS-PAGE
MW	Bos taurus	129000	*	*liver, nonreducing SDS-PAGE
MW	Homo sapiens	129000	*	*radiation inactivation, placenta
MW	Bos taurus	136000	*	*liver, nonreducing SDS-PAGE
MW	Homo sapiens	156000	*	*radiation inactivation, skin fibroblast
MW	Bos taurus	204600	*	*liver, Svedberg equation
MW	Bos taurus	270000	*	*fetal calf serum, gel filtration
MW	Bos taurus	272000	*	*liver, gel filtration
SA	Homo sapiens	4.2	*	*recombinant UCE expressed in CHO-K1 cells
SA	Homo sapiens	4.75	*	*recombinant UCE expressed in Sf9 insect cells
SA	Homo sapiens	15000	*	*purified enzyme
